Our Team

We have an amazing team of medical doctors, programmers, engineers, and designers committed to advancing pediatric neurofeedback technology.

Founders & Leadership

Our founding team brings together expertise in neuroscience, clinical neurofeedback, and medical technology development.

Vitali Karpeichyk

CEO & Co-Founder

Lena Labai

Chief Marketing Officer

Juan Ricardo Diaz

Co-Founder, Neurofeedback Expert

Nadzeya Kurchych

Chief Research Officer

Andrei Pliachko

CAO, Co-Founder, Brain Researcher

Darya Dubois

Chief Innovation, Strategy Officer

Executive Team

Our executive leaders drive marketing, research, innovation, and strategic growth.

Yuliya Shved

Legal

Consultant

Dzmitry Abramau

Firmware

Developer

Dmitry Kremez

Senior Electronics Engineer

Ivan Shmatko

Head 

of Design

Andrei Savich

Lead Design

Engineer

Advisory Board

We have unique advisors providing guidance on medical technology, autism advocacy, startup strategy, and product development.

David Maltz

Digital Medtech Advisor

Cathy Farmer

Autism Advocate, Startup Advisor

Johana Carolina Vega

Startup and VC Advisor

Andrew Sokol

Medical

Advisor

Giles Lowe

Development Strategies Adviser

Our Commitment to Clinical Excellence

MindMuscle was founded on the belief that neurofeedback technology should be held to the same standards as other clinical interventions: rigorous validation, transparent reporting, and ongoing accountability to patient outcomes.

We recognize that neurofeedback research has historically suffered from small sample sizes, inconsistent protocols, and publication bias. We are committed to advancing the field through structured clinical trials, open-source methodology, and collaboration with academic institutions.

Our team includes practicing clinicians who understand the realities of pediatric therapy environments. We design our technology to integrate seamlessly into existing workflows, support clinical decision-making, and provide meaningful data without creating additional burden.

Above all, we remain humble about what we know and transparent about what remains uncertain. Children with ADHD and autism deserve interventions backed by evidence, delivered by skilled clinicians, and continuously refined based on real-world outcomes.